(Q33289730)

25 July 2017

title

Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entry (English)

1 reference

25 July 2017

1 reference

James Irving

3

0 references

Ursula Dietrich

object named as

Ursula Dietrich

11

0 references

author name string

Christoph Königs

1

1 reference

25 July 2017

Anette Pustowka

2

1 reference

25 July 2017

Christoph Kessel

4

1 reference

25 July 2017

Katharina Klich

5

1 reference

25 July 2017

Valérie Wegner

6

1 reference

25 July 2017

Merrill J Rowley

7

1 reference

25 July 2017

Ian R Mackay

8

1 reference

25 July 2017

Wolfhart Kreuz

9

1 reference

25 July 2017

Christian Griesinger

10

1 reference

25 July 2017

publication date

3 July 2007

1 reference

Immunology & Cell Biology

25 July 2017

published in

1 reference

25 July 2017

volume

85

1 reference

25 July 2017

issue

7

1 reference

25 July 2017

page(s)

511-517

1 reference

The biology of chemokines and their receptors

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

HIV and the chemokine system: 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

The current status of, and challenges in, the development of CCR5 inhibitors as therapeutics for HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Epitope mapping of CCR5 reveals multiple conformational states and distinct but overlapping structures involved in chemokine and coreceptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

The role of CCR5 chemokine ligands and antibodies to CCR5 coreceptors in preventing HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-specific antibodies with human immunodeficiency virus-neutralizing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Regions in beta-chemokine receptors CCR5 and CCR2b that determine HIV-1 cofactor specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Molecular modeling and site-directed mutagenesis of CCR5 reveal residues critical for chemokine binding and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Monoclonal antibody screening of a phage-displayed random peptide library reveals mimotopes of chemokine receptor CCR5: implications for the tertiary structure of the receptor and for an N-terminal binding site for HIV-1 gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Requirement of multiple phage displayed peptide libraries for optimal mapping of a conformational antibody epitope on CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Crystal structure of rhodopsin: A G protein-coupled receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Protein disorder prediction: implications for structural proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

An overview of the determinants of CCR5 and CXCR4 co-receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Contrasting Use of CCR5 Structural Determinants by R5 and R5X4 Variants within a Human Immunodeficiency Virus Type 1 Primary Isolate Quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

CCR5 and CXCR4 usage by non-clade B human immunodeficiency virus type 1 primary isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Grafting segments from the extracellular surface of CCR5 onto a bacteriorhodopsin transmembrane scaffold confers HIV-1 coreceptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Specific inhibition of HIV-1 coreceptor activity by synthetic peptides corresponding to the predicted extracellular loops of CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Tyrosine-sulfated peptides functionally reconstitute a CCR5 variant lacking a critical amino-terminal region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

Differential inhibition of human immunodeficiency virus type 1 fusion, gp120 binding, and CC-chemokine activity by monoclonal antibodies to CCR5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

7 January 2021

Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

7 January 2021

A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

7 January 2021

Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

7 January 2021

CCR5-Mediated human immunodeficiency virus entry depends on an amino-terminal gp120-binding site and on the conformational integrity of all four extracellular domains

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100077

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100077

1 reference

25 July 2017

1 reference